Lianhuan Pharmaceutical announced that the company reviewed and passed the relevant bill on April 27, 2026. It plans to invest in the “Science and Technology Innovation Center Project” and the “Pharmaceutical Precision Cold Chain Manufacturing Center Project” in the Yangzhou High-tech Zone. The total planned investment amounts are 150 million yuan and 300 million yuan respectively. Recently, the company and its holding subsidiary Lianhuan Marketing have respectively signed a “Project Admission Contract” with the Yangzhou High-tech Zone Management Committee. If there are major changes or phased progress in subsequent developments, the company will promptly disclose them.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.